PL1812046T3 - Przeciwciała naśladowcze wiążące receptor melanokortyny, kompozycje, sposoby i zastosowania - Google Patents

Przeciwciała naśladowcze wiążące receptor melanokortyny, kompozycje, sposoby i zastosowania

Info

Publication number: PL1812046T3
Authority: PL; Poland
Prior art keywords: methods; receptor binding; compositions; melanocortin receptor; mimetibodies
Prior art date: 2004-10-25

Application number

PL05819741T

Other languages

English (en)

Inventor

Mark Cunningham

Vedrana Stojanovic-Susulic

Karyn O'neil

Chichi Huang

Jeffrey Luo

Original Assignee

Centocor Ortho Biotech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-25

Filing date

2005-10-25

Publication date

2011-08-31

2005-10-25 Application filed by Centocor Ortho Biotech Inc filed Critical Centocor Ortho Biotech Inc

2011-08-31 Publication of PL1812046T3 publication Critical patent/PL1812046T3/pl

Links

102000004378 Melanocortin Receptors Human genes 0.000 title abstract 2
108090000950 Melanocortin Receptors Proteins 0.000 title abstract 2
239000000203 mixture Substances 0.000 title 1
102000040430 polynucleotide Human genes 0.000 abstract 2
108091033319 polynucleotide Proteins 0.000 abstract 2
239000002157 polynucleotide Substances 0.000 abstract 2
229920001184 polypeptide Polymers 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
102000004196 processed proteins & peptides Human genes 0.000 abstract 2

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/68—Melanocyte-stimulating hormone [MSH]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Endocrinology (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Biophysics (AREA)
Hematology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL05819741T 2004-10-25 2005-10-25 Przeciwciała naśladowcze wiążące receptor melanokortyny, kompozycje, sposoby i zastosowania PL1812046T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US62196004P	2004-10-25	2004-10-25
PCT/US2005/038431 WO2006047535A2 (en)	2004-10-25	2005-10-25	Melanocortin receptor binding mimetibodies, compositions, methods and uses
EP05819741A EP1812046B1 (en)	2004-10-25	2005-10-25	Melanocortin receptor binding mimetibodies, compositions, methods and uses

Publications (1)

Publication Number	Publication Date
PL1812046T3 true PL1812046T3 (pl)	2011-08-31

Family

ID=36228385

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05819741T PL1812046T3 (pl)	2004-10-25	2005-10-25	Przeciwciała naśladowcze wiążące receptor melanokortyny, kompozycje, sposoby i zastosowania

Country Status (28)

Country	Link
US (1)	US20060105951A1 (pl)
EP (1)	EP1812046B1 (pl)
JP (1)	JP2008517605A (pl)
KR (1)	KR101255140B1 (pl)
CN (1)	CN101437540B (pl)
AT (1)	ATE501731T1 (pl)
AU (1)	AU2005299440B2 (pl)
BR (1)	BRPI0518411A2 (pl)
CA (1)	CA2585287A1 (pl)
CY (1)	CY1111486T1 (pl)
DE (1)	DE602005026970D1 (pl)
DK (1)	DK1812046T3 (pl)
EA (1)	EA200700944A1 (pl)
EC (1)	ECSP077416A (pl)
ES (1)	ES2363023T3 (pl)
HR (1)	HRP20110405T1 (pl)
IL (1)	IL182683A0 (pl)
MA (1)	MA28943B1 (pl)
ME (1)	ME01234B (pl)
MX (1)	MX2007004974A (pl)
NO (1)	NO20072499L (pl)
PL (1)	PL1812046T3 (pl)
PT (1)	PT1812046E (pl)
RS (1)	RS51789B (pl)
SI (1)	SI1812046T1 (pl)
TN (1)	TNSN07157A1 (pl)
WO (1)	WO2006047535A2 (pl)
ZA (1)	ZA200704260B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7910101B2 (en) *	2004-10-25	2011-03-22	Centocor, Inc.	Melanocortin receptor binding mimetibodies, compositions, methods and uses
US7790671B2 (en) *	2005-10-07	2010-09-07	Codman & Shurtleff, Inc.	Implantable pump for protein delivery for obesity control by drug infusion into the brain
AR072072A1 (es) *	2008-06-09	2010-08-04	Palatin Technologies Inc	Peptidos especificos del receptor de melanocortina para el tratamiento de la obesidad / 669
EP2300036B1 (en)	2008-06-09	2017-04-05	Palatin Technologies, Inc.	Melanocortin receptor-specific peptides for treatment of sexual dysfunction
US8614185B2 (en) *	2009-05-04	2013-12-24	Centocor Ortho Biotech Inc.	Fusion proteins of alpha-MSH derivatives and Fc
BRPI1009644B1 (pt)	2009-06-08	2022-02-08	Palatin Technologies, Inc	Peptídeo cíclico ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica e uso da composição farmacêutica
UY32690A (es)	2009-06-08	2011-01-31	Astrazeneca Ab	Péptidos específicos para receptores de melanocortina
WO2010144341A2 (en)	2009-06-08	2010-12-16	Palatin Technologies, Inc.	Lactam-bridged melanocortin receptor-specific peptides
EP2504351A4 (en)	2009-11-23	2013-10-30	Palatin Technologies Inc	MELANOCORTIN-1 RECEPTOR-SPECIFIC LINEAR PEPTIDE
AU2010321738B2 (en)	2009-11-23	2016-07-14	Palatin Technologies, Inc.	Melanocortin-1 receptor-specific cyclic peptides
JP2020141710A (ja) *	2011-07-06	2020-09-10	ゲンマブエー／エス	抗体重鎖のｃ末端の修飾による補体依存性細胞傷害の調節
WO2020177627A1 (zh) *	2019-03-02	2020-09-10	上海一宸医药科技有限公司	一种双特异抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA01005818A (es) *	1998-12-09	2003-07-21	Eleanor Rooseveltl Inst	Composicion y metodo para la regulacion del peso del cuerpo y condiciones asociadas.
WO2002006316A2 (en) *	2000-07-14	2002-01-24	Zycos, Inc.	Alpha-msh related compounds and methods of use
WO2004002417A2 (en) *	2002-06-28	2004-01-08	Centocor, Inc.	Mammalian ch1 deleted mimetibodies, compositions, methods and uses
US7241733B2 (en) *	2002-06-28	2007-07-10	Centocor, Inc.	Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
EP1750754A4 (en) *	2004-03-31	2010-09-22	Centocor Ortho Biotech Inc	HUMAN GLP-1 MIMETIC BODIES, COMPOSITIONS, METHODS AND USES

2005
- 2005-10-25 DK DK05819741.9T patent/DK1812046T3/da active
- 2005-10-25 PL PL05819741T patent/PL1812046T3/pl unknown
- 2005-10-25 ES ES05819741T patent/ES2363023T3/es not_active Expired - Lifetime
- 2005-10-25 HR HR20110405T patent/HRP20110405T1/hr unknown
- 2005-10-25 MX MX2007004974A patent/MX2007004974A/es unknown
- 2005-10-25 BR BRPI0518411-8A patent/BRPI0518411A2/pt not_active IP Right Cessation
- 2005-10-25 EP EP05819741A patent/EP1812046B1/en not_active Expired - Lifetime
- 2005-10-25 WO PCT/US2005/038431 patent/WO2006047535A2/en not_active Ceased
- 2005-10-25 EA EA200700944A patent/EA200700944A1/ru unknown
- 2005-10-25 KR KR1020077011487A patent/KR101255140B1/ko not_active Expired - Fee Related
- 2005-10-25 ME MEP-2011-85A patent/ME01234B/me unknown
- 2005-10-25 AU AU2005299440A patent/AU2005299440B2/en not_active Ceased
- 2005-10-25 CN CN2005800447902A patent/CN101437540B/zh not_active Expired - Fee Related
- 2005-10-25 RS RS20110230A patent/RS51789B/sr unknown
- 2005-10-25 DE DE602005026970T patent/DE602005026970D1/de not_active Expired - Lifetime
- 2005-10-25 US US11/257,851 patent/US20060105951A1/en not_active Abandoned
- 2005-10-25 CA CA002585287A patent/CA2585287A1/en not_active Abandoned
- 2005-10-25 PT PT05819741T patent/PT1812046E/pt unknown
- 2005-10-25 SI SI200531295T patent/SI1812046T1/sl unknown
- 2005-10-25 AT AT05819741T patent/ATE501731T1/de active
- 2005-10-25 JP JP2007538172A patent/JP2008517605A/ja active Pending
2007
- 2007-04-19 IL IL182683A patent/IL182683A0/en unknown
- 2007-04-23 MA MA29843A patent/MA28943B1/fr unknown
- 2007-04-24 TN TNP2007000157A patent/TNSN07157A1/fr unknown
- 2007-04-25 EC EC2007007416A patent/ECSP077416A/es unknown
- 2007-05-15 NO NO20072499A patent/NO20072499L/no not_active Application Discontinuation
- 2007-05-24 ZA ZA200704260A patent/ZA200704260B/xx unknown
2011
- 2011-05-23 CY CY20111100502T patent/CY1111486T1/el unknown

Also Published As

Publication number	Publication date
WO2006047535A2 (en)	2006-05-04
ATE501731T1 (de)	2011-04-15
HK1106445A1 (en)	2008-03-14
EP1812046B1 (en)	2011-03-16
PT1812046E (pt)	2011-06-28
SI1812046T1 (sl)	2011-06-30
ZA200704260B (en)	2009-03-25
CA2585287A1 (en)	2006-05-04
US20060105951A1 (en)	2006-05-18
WO2006047535A3 (en)	2008-09-04
IL182683A0 (en)	2007-09-20
RS51789B (sr)	2011-12-31
BRPI0518411A2 (pt)	2008-11-18
KR101255140B1 (ko)	2013-04-22
EA200700944A1 (ru)	2008-04-28
CY1111486T1 (el)	2015-08-05
HRP20110405T1 (hr)	2011-06-30
AU2005299440B2 (en)	2011-12-15
DK1812046T3 (da)	2011-06-06
CN101437540B (zh)	2012-12-19
CN101437540A (zh)	2009-05-20
NO20072499L (no)	2007-07-16
ECSP077416A (es)	2007-05-30
JP2008517605A (ja)	2008-05-29
MA28943B1 (fr)	2007-10-01
ME01234B (me)	2013-06-20
KR20070085416A (ko)	2007-08-27
DE602005026970D1 (de)	2011-04-28
EP1812046A2 (en)	2007-08-01
MX2007004974A (es)	2007-10-17
TNSN07157A1 (en)	2008-11-21
EP1812046A4 (en)	2009-11-11
ES2363023T3 (es)	2011-07-19
AU2005299440A1 (en)	2006-05-04

Publication	Publication Date	Title
ZA200704260B (en)	2009-03-25	Melanocortin receptor binding mimetibodies, compositions, methods and uses
WO2007041635A3 (en)	2008-11-13	Fc variants with optimized fc receptor binding properties
TW200611910A (en)	2006-04-16	Interferon-alpha polypeptides and conjugates
HRP20190220T1 (hr)	2019-03-22	Anti-il-23 protutijela, pripravci, postupci i upotrebe
WO2006083276A3 (en)	2009-04-16	Interferon-alpha polypeptides and conjugates
WO2007087139A3 (en)	2007-10-11	MESENCHYMAL STEM CELLS EXPRESSING TNF-α RECEPTOR
IL236427A0 (en)	2015-02-26	Human anti-23-il antibodies, preparations, methods and uses
TW200631594A (en)	2006-09-16	Toll like receptor 3 antagonists, methods and uses
IL189555A0 (en)	2008-08-07	Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof
MX2010007716A (es)	2010-08-04	Combinacion de una proteina de fusion del anticuerpo-il-2 de anti-edb fibronectina y una molecula que se une a celulas b, progenitores de la celula b y/o sus contrapartes cancerigenas.
EP1617802A4 (en)	2007-08-01	CNGH0010 SPECIFIC POLYNUCLEOTIDES, POLYPEPTIDES, ANTIBODIES, COMPOSITIONS, METHODS AND USES
EP2214690A4 (en)	2012-05-09	THE MELANOCORTIN RECEPTOR BINDING MIMIC BODIES, COMPOSITIONS, PROCESSES AND USES
WO2007044083A3 (en)	2009-04-16	Evolved interferon-alpha polypeptides
TW200745159A (en)	2007-12-16	IL-6 binding proteins
WO2006018650A3 (en)	2006-04-27	Method of in vitro polypeptide selection using the arc dna binding domain fused to the polypeptide to be selected
MX296535B (es)	2012-02-29	Enzima laccasa novedosa y uso de la misma.
TW200711846A (en)	2007-04-01	Composite materials and methods of making the same
EP1828237A4 (en)	2008-06-11	HUMAN CANCER SUPPRESSOR GENE, PROTEIN ENCODED THEREIN, EXPRESSION VECTOR CONTAINING THE GENE, AND CELL TRANSFORMED BY THE VECTOR
WO2007056760A3 (en)	2008-02-28	Hcv-reactive t cell receptors
SG158098A1 (en)	2010-01-29	Toll like receptor 3 antagonists, methods and uses
AU2014210609B9 (en)	2016-07-21	Novel activin receptor and uses thereof
WO2005082088A3 (en)	2006-10-05	Functional genomics and gene trapping in haploid or hypodiploid cells
WO2005026207A3 (en)	2005-05-12	Adipocyte complement related protein zacrp12
GB2418913C (en)	2008-08-15	Improved peat substitute.
EP1844065A4 (en)	2008-08-20	POLYPEPTIDE WITH PYRIDOXIN BIOSYNTHESIS FUNCTION, POLYNUCLEOTIDE FOR CODING THE POLYPEPTIDE AND THEIR USE